164 related articles for article (PubMed ID: 26087014)
1. The outcome and role of drugs in patients with unexplained gastrointestinal bleeding.
Hreinsson JP; Bjarnason I; Bjornsson ES
Scand J Gastroenterol; 2015; 50(12):1482-9. PubMed ID: 26087014
[TBL] [Abstract][Full Text] [Related]
2. Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting.
Hreinsson JP; Gumundsson S; Kalaitzakis E; Björnsson ES
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):37-43. PubMed ID: 23013623
[TBL] [Abstract][Full Text] [Related]
3. The Association of Drugs With Severity and Specific Causes of Acute Lower Gastrointestinal Bleeding: A Prospective Study.
Hreinsson JP; Palsdóttir S; Bjornsson ES
J Clin Gastroenterol; 2016; 50(5):408-13. PubMed ID: 26280706
[TBL] [Abstract][Full Text] [Related]
4. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting.
Hreinsson JP; Kalaitzakis E; Gudmundsson S; Björnsson ES
Scand J Gastroenterol; 2013 Apr; 48(4):439-47. PubMed ID: 23356751
[TBL] [Abstract][Full Text] [Related]
5. The role of capsule endoscopy in the evaluation and treatment of obscure-overt gastrointestinal bleeding during daily clinical practice: a prospective multicenter study.
Katsinelos P; Lazaraki G; Gkagkalis A; Gatopoulou A; Patsavela S; Varitimiadis K; Mimidis K; Paroutoglou G; Koufokotsios A; Maris T; Terzoudis S; Gigi E; Chatzimavroudis G; Zavos C; Kountouras J
Scand J Gastroenterol; 2014 Jul; 49(7):862-70. PubMed ID: 24940823
[TBL] [Abstract][Full Text] [Related]
6. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
[TBL] [Abstract][Full Text] [Related]
7. Occult vs. overt upper gastrointestinal bleeding - inverse relationship and the use of mucosal damaging and protective drugs.
Taha AS; McCloskey C; Craigen T; Simpson A; Angerson WJ
Aliment Pharmacol Ther; 2015 Aug; 42(3):375-82. PubMed ID: 26011636
[TBL] [Abstract][Full Text] [Related]
8. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
[TBL] [Abstract][Full Text] [Related]
9. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
[TBL] [Abstract][Full Text] [Related]
10. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage.
Khalid F; Qureshi W; Qureshi S; Alirhayim Z; Garikapati K; Patsias I
Ren Fail; 2013 Oct; 35(9):1228-35. PubMed ID: 23902367
[TBL] [Abstract][Full Text] [Related]
11. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Delaney JA; Opatrny L; Brophy JM; Suissa S
CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
[TBL] [Abstract][Full Text] [Related]
12. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.
Chen WC; Chen YH; Hsu PI; Tsay FW; Chan HH; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():463767. PubMed ID: 24987683
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding.
Crooks CJ; West J; Card TR
Gastroenterology; 2013 Jun; 144(7):1384-93, 1393.e1-2; quiz e18-9. PubMed ID: 23470619
[TBL] [Abstract][Full Text] [Related]
15. Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding.
Fry LC; Bellutti M; Neumann H; Malfertheiner P; Mönkemüller K
Aliment Pharmacol Ther; 2009 Feb; 29(3):342-9. PubMed ID: 19035975
[TBL] [Abstract][Full Text] [Related]
16. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.
Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2014 Oct; 29(10):1786-93. PubMed ID: 24720424
[TBL] [Abstract][Full Text] [Related]
17. Are repeat upper gastrointestinal endoscopy and colonoscopy necessary within six months of capsule endoscopy in patients with obscure gastrointestinal bleeding?
Gilbert D; O'Malley S; Selby W
J Gastroenterol Hepatol; 2008 Dec; 23(12):1806-9. PubMed ID: 19032448
[TBL] [Abstract][Full Text] [Related]
18. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
[TBL] [Abstract][Full Text] [Related]
19. Management of Anticoagulants and Antiplatelet Agents During Colonoscopy.
Feagins LA
Am J Med; 2017 Jul; 130(7):786-795. PubMed ID: 28344132
[TBL] [Abstract][Full Text] [Related]
20. Negative capsule endoscopy for obscure gastrointestinal bleeding is closely associated with the use of low-dose aspirin.
Matsumura T; Arai M; Sazuka S; Saito M; Takahashi Y; Maruoka D; Suzuki T; Nakagawa T; Sato T; Katsuno T; Imazeki F; Yokosuka O
Scand J Gastroenterol; 2011 May; 46(5):621-6. PubMed ID: 21189093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
